Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

368 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-19

Study Completion Date

2028-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Development and validation study of a prognostic score - study of prognostic performance by a prospective longitudinal multicenter cohort spread over 8 centers: 4 for the development cohort and 4 for the validation cohort).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Wheelchair Positioning and Neuromuscular Diseases

NCT05006859

Neuromuscular Diseases

RECRUITING

Wheelchair Positioning and Pain in Neuromuscular Patients

NCT02141724

Adult Patients With Neuromuscular Disorders Using Wheelchair

COMPLETED

Positioning in Wheelchair Bound Patients

NCT05653089

Neurological Disease

UNKNOWN NA

Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor

NCT04335942

Duchenne Muscular Dystrophy Spinal Muscular Atrophy

COMPLETED NA

Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device

NCT03611244

Scoliosis Neuromuscular Duchenne Muscular Dystrophy Lordosis Lumbar

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Progressive muscle weakness in neuromuscular diseases leads to motor disabilities leading to permanentfull-time wheelchair use. This is the case for infantile spinal muscular atrophy type II (SMA II), where people are dependent on a permanent sitting position from early childhood, at 2 years of age, or for Duchenne muscular dystrophy, when they lose their ability to walk around 10 years without corticosteroid therapy or around 13 years with treatment. These wheelchair users, weakened by the disease, are subject to musculotendinous retractions, osteo-articular stiffness, spinal deformities and pain. In addition, they use the wheelchair on a daily basis, on average 12 hours a day, whose permanent sitting position also conditions the performance of achieving life habits.

The analysis of the static and dynamic seated postural installation in the wheelchair makes it possible to avoid harmful consequences on the health and quality of life of users on a daily basis. When performed early enough, regularly and optimally, it also contributes to the prevention of complications.

In France, these assessments are carried out by occupational therapists, accompanied by doctors of Physical Medicine and Rehabilitation.

The weakness of the literature in this area and the absence of recommendations do not allow the user or any health professional to identify the need and the level of urgency to benefit from a dedicated consultation.

Faced with this observation, the development of a prognostic score for a change in positioning in the wheelchair, based on a prospective multicenter cohort and its validation on an external prospective cohort, will allow any healthcare professional to guide the user to a necessary positioning consultation. The hypothesis is that this score has discriminating qualities and that it is calibrated to predict a change in the seat of the RF and therefore the need to reassess the seated postural installation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

development cohort

Neuromuscular diseases

usual care

Intervention Type OTHER

For each cohort, the patient is seen at least twice, during annual visits in multidisciplinary consultation.

validation cohort

Neuromuscular diseases

usual care

Intervention Type OTHER

For each cohort, the patient is seen at least twice, during annual visits in multidisciplinary consultation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

usual care

For each cohort, the patient is seen at least twice, during annual visits in multidisciplinary consultation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female over the age of 18
* Daily wheelchair user (more than 4 hours per day)
* Having a neuromuscular disease such as Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II
* Accompanied by an identified medical equipment provider, able to respond to the recommendations of the clinical team
* Patient informed and having signed consent.

Exclusion Criteria

* Person who already has a seat change or FR prescription at the time of inclusion
* Having undergone surgery less than 1 year ago or a fracture
* Pregnant or breastfeeding women
* Patient under guardianship or curatorship.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No